Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.

TSX:TH - Post by User

Theratechnologies Inc > Very difficult to be constructive

<< Previous

Bullboard Posts

Next >>

Comment by Bucknelly21on Mar 02, 2022 7:25pm

121 Views

Post# 34477214

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Very difficult to be constructive

If only they would just be open to new ideas I think the bottom line is that they're just very stubborn they think they know better than everyone else which is funny because I have went nowhere in the last 25 years

<< Previous

Bullboard Posts

Next >>

Mid-year update: Charting GameSquare’s sharp business growth